IME To Develop First-Of-Its-Kind Silicon Nanowire Biochip For Genetic Testing With Singapore And Australian Biotech Companies

Singapore, 14 February 2007 – The potential development of a new highly sensitive biochip based on silicon nanowire technology will soon revolutionise the detection and analysis of RNA and DNA, which is central to many areas of healthcare and the life sciences, ranging from uncovering and diagnosing disease to the discovery and screening of new drugs.

MORE ON THIS TOPIC